Screening for oral cancer in tobacco and/or alcohol addicts: A comparison of different organizations
2017; Elsevier BV; Volume: 171; Linguagem: Inglês
10.1016/j.drugalcdep.2016.08.488
ISSN1879-0046
Autores Tópico(s)Tannin, Tannase and Anticancer Activities
ResumoIn 1989, the anti-cancer drug Navelbine®, whose International Nonproprietary Name (INN) is vinorelbine, was commercialized by Laboratoires Pierre Fabre, ten years after its discovery by Potier’s team at the ICSN in Gif-sur-Yvette. The name “navelbine”, given at the start by the researchers of that team, comes from the contraction of nor-anhydrovinblastine, whose structure resembles that of vinblastine – a natural antitumoral compound isolated from Catharanthus roseus, and commercialized under the name of Velbe® in 1961 by Eli Lilly.
Referência(s)